1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Volpon, L.
Lamthanh, H.
Barbier, J.
Gilles, N.
Molgo, J.
Menez, A.
Lancelin, J.M.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C5 H9 N O3
131.130
n
4-HYDROXYPROLINE
HYDROXYPROLINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
H2 N
16.023
AMINO GROUP
non-polymer
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
J.Biol.Chem.
JBCHA3
0071
0021-9258
279
21356
21366
10.1074/jbc.M309594200
14976206
NMR Solution Structures of delta-Conotoxin EVIA from Conus ermineus That Selectively Acts on Vertebrate Neuronal Na+ Channels.
2004
To be Published
0353
Conotoxin EVIA, a Novel Peptide from Conus ermineus Venom that Preferentially Acts on Neuronal Voltage-dependent Sodium Channels
10.2210/pdb1g1p/pdb
pdb_00001g1p
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1
SINGLE WAVELENGTH
M
1
1.0
THIS STRUCTURE IS IN EQUILIBRIUM WITH THE LEU12-PRO13 CIS ISOMER (1G1Z).
3294.909
CONOTOXIN EVIA
1
syn
polymer
no
yes
DDCIK(HYP)YGFCSLPILKNGLCCSGACVGVCADL(NH2)
DDCIKPYGFCSLPILKNGLCCSGACVGVCADLX
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
database_2
pdbx_nmr_software
pdbx_struct_assembly
pdbx_struct_oper_list
struct_conn
struct_site
repository
Initial release
Version format compliance
Version format compliance
Data collection
Database references
Derived calculations
1
0
2000-11-01
1
1
2008-04-01
1
2
2011-07-13
1
3
2022-02-23
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_nmr_software.name
_struct_conn.pdbx_dist_value
_struct_conn.pdbx_leaving_atom_flag
_struct_conn.ptnr1_auth_comp_id
_struct_conn.ptnr1_auth_seq_id
_struct_conn.ptnr1_label_comp_id
_struct_conn.ptnr1_label_seq_id
_struct_conn.ptnr2_auth_comp_id
_struct_conn.ptnr2_auth_seq_id
_struct_conn.ptnr2_label_comp_id
_struct_conn.ptnr2_label_seq_id
_struct_site.pdbx_auth_asym_id
_struct_site.pdbx_auth_comp_id
_struct_site.pdbx_auth_seq_id
1G1Z represents the conotoxin EVIA with the Leu12-Pro13 cis peptide bond.
RCSB
Y
RCSB
2000-10-13
REL
REL
The solid phase synthesis of conotoxin EVIA was carried out using the F-moc chemistry. The sequence of the peptide is naturally found in Conus ermineus (Atlantic fish-hunting cone).
sample
This structure was determined using standard 2D homonuclear techniques
structures with the least restraint violations,structures with the lowest energy
30
18
NOESY
DQF-COSY
0.01
3.0
ambient
283
K
the structures are based on a total of 256 restraints, 210 are NOE-derived distance constraints, 24 dihedral angle restraints and 22 distance restraints from hydrogen bonds.
hybrid distance geometry dynamical simulated annealing with the allhdg force field and simulated annealing with the CHARMM22 force field
13
closest to the average
2mM conotoxin EVIA; 90% H2O, 10% D2O
90% H2O/10% D2O
Bruker
collection
XwinNMR
2.6
Delsuc
data analysis
Gifa
4.22
Brunger
refinement
X-PLOR
3.851
Brooks
refinement
CHARMM
22
500
Bruker
DRX
ASP
1
n
1
ASP
1
A
ASP
2
n
2
ASP
2
A
CYS
3
n
3
CYS
3
A
ILE
4
n
4
ILE
4
A
LYS
5
n
5
LYS
5
A
HYP
6
n
6
HYP
6
A
TYR
7
n
7
TYR
7
A
GLY
8
n
8
GLY
8
A
PHE
9
n
9
PHE
9
A
CYS
10
n
10
CYS
10
A
SER
11
n
11
SER
11
A
LEU
12
n
12
LEU
12
A
PRO
13
n
13
PRO
13
A
ILE
14
n
14
ILE
14
A
LEU
15
n
15
LEU
15
A
LYS
16
n
16
LYS
16
A
ASN
17
n
17
ASN
17
A
GLY
18
n
18
GLY
18
A
LEU
19
n
19
LEU
19
A
CYS
20
n
20
CYS
20
A
CYS
21
n
21
CYS
21
A
SER
22
n
22
SER
22
A
GLY
23
n
23
GLY
23
A
ALA
24
n
24
ALA
24
A
CYS
25
n
25
CYS
25
A
VAL
26
n
26
VAL
26
A
GLY
27
n
27
GLY
27
A
VAL
28
n
28
VAL
28
A
CYS
29
n
29
CYS
29
A
ALA
30
n
30
ALA
30
A
ASP
31
n
31
ASP
31
A
LEU
32
n
32
LEU
32
A
NH2
33
n
33
NH2
33
A
author_defined_assembly
1
monomeric
A
HYP
6
4-HYDROXYPROLINE
A
HYP
6
PRO
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
2
A
A
HG
O
SER
ALA
22
30
1.60
3
A
A
HG
O
SER
ALA
22
30
1.59
4
A
A
HG
O
SER
ALA
22
30
1.60
10
A
A
HG
O
SER
ALA
22
30
1.60
11
A
A
HG
O
SER
ALA
22
30
1.57
12
A
A
HG
O
SER
ALA
22
30
1.60
13
A
A
HG
O
SER
ALA
22
30
1.58
15
A
A
HG
O
SER
LYS
11
16
1.57
17
A
A
HG
OD1
SER
ASN
11
17
1.57
4
A
A
GLY
ALA
23
24
-149.46
5
A
A
PRO
ILE
13
14
-149.45
13
A
A
PRO
ILE
13
14
-147.54
11
A
TYR
7
0.070
SIDE CHAIN
1
-16.71
2.70
111.00
94.29
A
A
A
N
CA
C
ILE
ILE
ILE
14
14
14
N
1
-16.73
2.70
111.00
94.27
A
A
A
N
CA
C
LEU
LEU
LEU
32
32
32
N
2
-16.39
2.70
111.00
94.61
A
A
A
N
CA
C
LEU
LEU
LEU
32
32
32
N
3
-17.04
2.70
111.00
93.96
A
A
A
N
CA
C
LEU
LEU
LEU
32
32
32
N
4
-16.88
2.70
111.00
94.12
A
A
A
N
CA
C
LYS
LYS
LYS
16
16
16
N
4
-17.82
2.50
113.10
95.28
A
A
A
N
CA
C
GLY
GLY
GLY
18
18
18
N
7
-17.62
2.70
111.00
93.38
A
A
A
N
CA
C
SER
SER
SER
11
11
11
N
7
-15.82
2.50
113.10
97.28
A
A
A
N
CA
C
GLY
GLY
GLY
18
18
18
N
8
-16.87
2.50
113.10
96.23
A
A
A
N
CA
C
GLY
GLY
GLY
18
18
18
N
9
-16.52
2.70
111.00
94.48
A
A
A
N
CA
C
LEU
LEU
LEU
32
32
32
N
10
-16.74
2.50
113.10
96.36
A
A
A
N
CA
C
GLY
GLY
GLY
18
18
18
N
11
-17.06
2.70
111.00
93.94
A
A
A
N
CA
C
LEU
LEU
LEU
32
32
32
N
13
-16.64
2.70
111.00
94.36
A
A
A
N
CA
C
LEU
LEU
LEU
32
32
32
N
14
-16.57
2.70
111.00
94.43
A
A
A
N
CA
C
LEU
LEU
LEU
12
12
12
N
14
-16.99
2.50
113.10
96.11
A
A
A
N
CA
C
GLY
GLY
GLY
18
18
18
N
14
-16.50
2.70
111.00
94.50
A
A
A
N
CA
C
LEU
LEU
LEU
32
32
32
N
15
-17.27
2.50
113.10
95.83
A
A
A
N
CA
C
GLY
GLY
GLY
18
18
18
N
15
-18.33
2.70
111.00
92.67
A
A
A
N
CA
C
VAL
VAL
VAL
26
26
26
N
15
-16.34
2.70
111.00
94.66
A
A
A
N
CA
C
LEU
LEU
LEU
32
32
32
N
17
-17.16
2.70
111.00
93.84
A
A
A
N
CA
C
LEU
LEU
LEU
19
19
19
N
17
-18.31
2.70
111.00
92.69
A
A
A
N
CA
C
VAL
VAL
VAL
26
26
26
N
17
-16.59
2.70
111.00
94.41
A
A
A
N
CA
C
LEU
LEU
LEU
32
32
32
N
18
9.63
1.50
110.50
120.13
A
A
A
N
CA
CB
SER
SER
SER
11
11
11
N
18
-17.60
2.70
111.00
93.40
A
A
A
N
CA
C
SER
SER
SER
11
11
11
N
18
-18.21
2.50
113.10
94.89
A
A
A
N
CA
C
GLY
GLY
GLY
18
18
18
N
18
-16.72
2.70
111.00
94.28
A
A
A
N
CA
C
LEU
LEU
LEU
32
32
32
N
1
A
ASP
2
178.85
-170.98
1
A
ALA
30
-121.48
-156.80
2
A
SER
11
-121.32
-80.11
2
A
LEU
15
52.63
-121.37
2
A
LEU
19
-118.66
72.65
2
A
VAL
26
-133.24
-138.60
2
A
ALA
30
-151.50
-146.10
3
A
ASP
2
-88.65
-147.78
3
A
SER
11
154.89
-89.06
3
A
LEU
15
-109.63
59.54
3
A
LYS
16
73.68
-58.24
3
A
VAL
26
-141.77
41.47
3
A
ALA
30
-145.89
-140.70
4
A
CYS
3
-118.75
-169.75
4
A
SER
11
172.29
-158.76
4
A
LEU
19
-129.30
-165.14
4
A
ALA
30
-144.26
-146.75
5
A
ILE
14
-72.52
29.97
5
A
VAL
26
-146.47
48.29
5
A
ALA
30
-133.78
-142.77
6
A
ASP
2
-109.27
-113.38
6
A
LYS
16
-59.75
106.36
6
A
VAL
26
-149.16
51.50
7
A
SER
11
168.79
-145.98
7
A
PRO
13
-140.76
28.96
7
A
ILE
14
-126.03
-55.73
7
A
LEU
15
-124.19
-162.59
7
A
LYS
16
-95.46
34.62
7
A
VAL
26
-142.67
39.03
7
A
ALA
30
-148.35
-152.93
7
A
ASP
31
-175.10
-171.87
8
A
ASP
2
-103.94
-114.77
8
A
ILE
14
72.85
-58.86
8
A
VAL
26
-142.46
42.91
8
A
ALA
30
-129.55
-164.44
9
A
SER
11
-168.83
-169.90
9
A
ILE
14
-142.75
-90.16
9
A
VAL
26
-127.68
-125.81
9
A
ALA
30
-128.28
-165.46
10
A
ASP
2
-90.60
-133.53
10
A
SER
11
-169.48
-168.12
10
A
ILE
14
-151.06
-50.67
10
A
LEU
15
-125.58
-163.10
10
A
VAL
26
-152.44
62.80
10
A
ALA
30
-125.55
-147.56
11
A
CYS
10
-117.17
-118.35
11
A
SER
11
-154.13
-136.85
11
A
LEU
15
-108.95
-72.08
11
A
LYS
16
-124.15
-96.95
11
A
ASN
17
177.66
-165.20
11
A
VAL
26
-151.21
65.45
11
A
ALA
30
-139.45
-152.36
12
A
ASP
2
-102.69
-106.17
12
A
SER
11
-174.49
-156.55
12
A
ILE
14
-164.60
-51.42
12
A
LEU
15
-115.00
-158.28
12
A
ASN
17
-176.26
-171.97
12
A
VAL
26
-158.19
55.98
12
A
ALA
30
-145.62
-149.39
13
A
CYS
10
-106.82
78.98
13
A
LEU
15
-158.69
-54.91
13
A
VAL
26
-149.60
43.57
13
A
ALA
30
-148.62
-146.62
14
A
ASP
2
-97.65
-68.91
14
A
SER
11
167.57
-174.48
14
A
VAL
26
-146.88
44.78
15
A
PRO
13
-73.65
41.25
15
A
LEU
15
-127.38
-137.38
15
A
VAL
26
-160.69
-140.55
15
A
ALA
30
-141.22
-154.93
16
A
CYS
3
-171.32
-175.72
16
A
SER
11
-175.02
-158.63
16
A
ILE
14
171.09
-39.75
16
A
LYS
16
-95.97
54.99
16
A
VAL
26
-150.61
56.54
16
A
ALA
30
-142.79
-141.63
17
A
ASP
2
67.71
-148.49
17
A
SER
11
-87.16
-105.82
17
A
ILE
14
-140.21
-68.48
17
A
VAL
26
-160.31
-142.92
17
A
ALA
30
-144.23
-155.17
18
A
ASP
2
-113.82
-74.67
18
A
SER
11
141.20
-139.30
18
A
ILE
14
75.03
-64.90
18
A
VAL
26
-135.19
-129.87
18
A
ALA
30
-152.11
-151.23
NMR Solution Structures of delta-Conotoxin EVIA from Conus ermineus that Selectively Acts on Vertebrate Neuronal Na+ Channels
1
N
N
disulf
2.027
A
CYS
3
A
SG
CYS
3
1_555
A
CYS
21
A
SG
CYS
21
1_555
disulf
2.019
A
CYS
10
A
SG
CYS
10
1_555
A
CYS
25
A
SG
CYS
25
1_555
disulf
2.019
A
CYS
20
A
SG
CYS
20
1_555
A
CYS
29
A
SG
CYS
29
1_555
covale
1.328
both
A
LYS
5
A
C
LYS
5
1_555
A
HYP
6
A
N
HYP
6
1_555
covale
1.354
both
A
HYP
6
A
C
HYP
6
1_555
A
TYR
7
A
N
TYR
7
1_555
covale
1.356
both
A
LEU
32
A
C
LEU
32
1_555
A
NH2
33
A
N
NH2
33
1_555
TOXIN
three disulfide linkages, cis/trans isomerism of Leu12-Pro13 peptide bond, hydroxyproline, TOXIN
CXD6A_CONER
UNP
1
1
P60513
1
32
1G1P
1
32
P60513
A
1
1
32
BINDING SITE FOR RESIDUE NH2 A 33
A
NH2
33
Software
1
A
LEU
32
A
LEU
32
1
1_555
1
P 1